<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title><![CDATA[Natpar (parathyroid hormone) - Shire Pharmaceuticals Ireland Limited]]></title>
    <ttl>1440</ttl>
    <copyright>Copyright: (C) European Commission</copyright>
    <language>en-gb</language>
    <atom:link href="http://ec.europa.eu/health/documents/community-register/html/rss/h1078.rss" rel="self" type="application/rss+xml" />
    <lastBuildDate>Wed, 26 Apr 2017 12:04:00 +0000</lastBuildDate>
    <link>http://ec.europa.eu/health/documents/community-register/html/h1078.htm</link>
    <description><![CDATA[Natpar (Active substance: parathyroid hormone) - EU number: EU/1/15/1078 - Marketing authorisation holder: Shire Pharmaceuticals Ireland Limited]]>
    </description>
    <image>
        <title><![CDATA[Natpar (parathyroid hormone) - Shire Pharmaceuticals Ireland Limited]]></title>
        <url>http://ec.europa.eu/health/documents/community-register/images/logo_en.gif</url>
        <link>http://ec.europa.eu/health/documents/community-register/html/h1078.htm</link>
        <width>144</width>
        <height>100</height>
    </image>
    <item>
        <title>Centralised - Authorisation - Commission Decision (2017)2858 of Wed, 26 Apr 2017</title>
        <category>New documents</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/h1078.htm#proc137423</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/h1078.htm#proc137423</link>
        <description><![CDATA[Centralised - Authorisation) - Commission Decision (2017)2858 of Wed, 26 Apr 2017 - European Medicines Agency (EMA) procedure number: EMEA/H/C/3861/00]]></description>
        <pubDate>Wed, 26 Apr 2017 12:04:00 +0000</pubDate>
    </item>
    </channel>
</rss>
